US 11390687
Bispecific antibodies against plasma kallikrein and Factor XII
granted A61KA61K39/395A61P
Quick answer
US patent 11390687 (Bispecific antibodies against plasma kallikrein and Factor XII) held by Takeda Pharmaceutical Company Limited expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K39/395, A61P, A61P7/02